1. Home
  2. APLT vs ODP Comparison

APLT vs ODP Comparison

Compare APLT & ODP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • ODP
  • Stock Information
  • Founded
  • APLT 2016
  • ODP 1986
  • Country
  • APLT United States
  • ODP United States
  • Employees
  • APLT N/A
  • ODP N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • ODP Other Specialty Stores
  • Sector
  • APLT Health Care
  • ODP Consumer Discretionary
  • Exchange
  • APLT Nasdaq
  • ODP Nasdaq
  • Market Cap
  • APLT 128.0M
  • ODP 690.3M
  • IPO Year
  • APLT 2019
  • ODP N/A
  • Fundamental
  • Price
  • APLT $0.90
  • ODP $22.00
  • Analyst Decision
  • APLT Buy
  • ODP Hold
  • Analyst Count
  • APLT 7
  • ODP 1
  • Target Price
  • APLT $6.10
  • ODP $28.00
  • AVG Volume (30 Days)
  • APLT 8.4M
  • ODP 604.1K
  • Earning Date
  • APLT 11-07-2024
  • ODP 02-26-2025
  • Dividend Yield
  • APLT N/A
  • ODP N/A
  • EPS Growth
  • APLT N/A
  • ODP N/A
  • EPS
  • APLT N/A
  • ODP N/A
  • Revenue
  • APLT N/A
  • ODP $7,178,000,000.00
  • Revenue This Year
  • APLT N/A
  • ODP N/A
  • Revenue Next Year
  • APLT $2,664.24
  • ODP N/A
  • P/E Ratio
  • APLT N/A
  • ODP N/A
  • Revenue Growth
  • APLT N/A
  • ODP N/A
  • 52 Week Low
  • APLT $0.77
  • ODP $21.66
  • 52 Week High
  • APLT $10.62
  • ODP $58.13
  • Technical
  • Relative Strength Index (RSI)
  • APLT 19.46
  • ODP 31.00
  • Support Level
  • APLT $0.78
  • ODP $21.66
  • Resistance Level
  • APLT $0.90
  • ODP $27.59
  • Average True Range (ATR)
  • APLT 0.12
  • ODP 1.15
  • MACD
  • APLT 0.26
  • ODP -0.35
  • Stochastic Oscillator
  • APLT 20.97
  • ODP 5.14

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About ODP The ODP Corporation

The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on global operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue primarily stems from the Veyer division.

Share on Social Networks: